TOKYO, Jan 18, 2023 – (JCN Newswire) – Eisai Co., Ltd. announced today the presentation of research across various types of gastrointestinal cancers during the 2023 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (#GI23), which is taking place in-person in San Francisco, California and virtually from January 19-21.Notable data include an update from the dose-escalation part of a Phase 1 Study evaluating E7386(1…
Read More
About The Author
